Dados B3 › RNEW3 × CPFE3
RNEW3 × CPFE3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | RNEW3 | CPFE3 | year |
|---|---|---|---|
| ROE | 0.0% | 25.4% | 2025 |
| ROIC | -0.1%! | 16.2% | 2025 |
| ROA | -5.3% | 7.3% | 2025 |
| Gross margin | -4.7% | 31.8% | 2025 |
| EBIT margin | -0.4% | 24.9% | 2025 |
| Net margin | -31.5% | 12.9% | 2025 |
| Net debt/EBITDA | 6.06x | 1.94x | 2025 |
| Current ratio | 0.84x | 0.93x | 2025 |
| Revenue growth (1y) | 98.7% | 4.1% | 2025 |
| Revenue growth (5y CAGR) | 48.8% | 7.5% | 2025 |
| Piotroski F-Score | 6/9 | 6/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | RNEW3 | CPFE3 | year |
|---|---|---|---|
| P/E | — | 9.86x | 2025 |
| P/B | 0.34x | 2.41x | 2025 |
| EV/EBITDA | 9.69x | 5.97x | 2025 |
| FCF yield | -18.9% | 12.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 05:35 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 05:35 UTC. If this does not match /saude, you are reading a cached copy.